Changes to the Code
H.R. 5844 · Harm Reduction Through Community Engagement Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 823 Registration requirements
7 changes the bill asks for here, 3 carried out
- Carried out:
by redesignating paragraphs (1), (2), and (3) as subparagraphs (A), (B), and (C), respectively, and moving the margins of such subparagraphs (as so redesignated) two ems to the right;
- Not carried out:
by striking (h) Practitioners who and inserting the following:(h) Maintenance treatment or detoxification treatment registration requirements.— (1) In general.— Practitioners who;
The bill gives this provision a heading and rewords it at the same time, a kind of change we can't show yet.
Technical detail
the provision inserted says more than a heading and the words struck - Not carried out:
in subparagraph (B) (as so redesignated), by striking
and
at the end;The bill points to paragraph (1) of § 823(h), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.
Technical detail
target not found: no paragraph (1) in /us/usc/t21/s823/h - Not carried out:
in subparagraph (C) (as so redesignated), by striking the period at the end and inserting
; and
; andThe bill points to paragraph (1) of § 823(h), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.
Technical detail
target not found: no paragraph (1) in /us/usc/t21/s823/h - Not carried out:
by adding at the end the following:
(D) if the Secretary determines that— (i) the applicant will address community impacts in accordance with paragraph (2); (ii) the treatment will not be provided within one-half mile of a public or private licensed day care center, a public or private elementary or secondary …
The bill points to paragraph (1) of § 823(h), which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.
Technical detail
target not found: no paragraph (1) in /us/usc/t21/s823/h - Carried out:
Section 303(h) of the Controlled Substances Act (21 U.S.C. 823(h)), as amended by subsection (a), is further amended by adding at the end the following:
(2) Community impact consideration.— For purposes of being determined to be qualified under paragraph (1)(A), a practitioner seeking to become registered or maintain registration under paragraph (1) to dispense narcotic drugs to individuals for maintenance treatment or …
- Carried out:
Section 303(h) of the Controlled Substances Act (21 U.S.C. 823(h)), as amended by subsections (a) and (b), is further amended by adding at the end the following:
(3) Reporting to Congress.— Not later than 1 year after the date of enactment of the Harm Reduction Through Community Engagement Act of 2025, and annually thereafter, the Secretary shall submit to the Congress a comprehensive report on community engagement and the maintenance of …
§ 823(g)–(i)
Start of § 823 to (g)(2)(B)(vi)(IV)(cc) unchanged ·
(3) Article 7 of the Convention on Psychotropic Substances shall not be construed to prohibit, or impose additional restrictions upon, research involving drugs or other substances scheduled under the convention which is conducted in conformity with this subsection and other applicable provisions of this subchapter.
(h) Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate registration; qualifications Practitioners who dispense narcotic drugs (other than narcotic drugs in schedule III, IV, or V) to individuals for maintenance treatment or detoxification treatment shall obtain annually a separate registration for that purpose. The Attorney General shall register an applicant to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment (or both)—
[struck: (1)] [inserted: (A)] if the applicant is a practitioner who is determined by the Secretary to be qualified (under standards established by the Secretary) to engage in the treatment with respect to which registration is sought;
[struck: (2)] [inserted: (B)] if the Attorney General determines that the applicant will comply with standards established by the Attorney General respecting (A) security of stocks of narcotic drugs for such treatment, and (B) the maintenance of records (in accordance with section 827 of this title) on such drugs; and
[struck: (3)] [inserted: (C)] if the Secretary determines that the applicant will comply with standards established by the Secretary (after consultation with the Attorney General) respecting the quantities of narcotic drugs which may be provided for unsupervised use by individuals in such treatment.
(2) [inserted: Community impact consideration.—] [inserted: For purposes of being determined to be qualified under paragraph (1)(A), a practitioner seeking to become registered or maintain registration under paragraph (1) to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment shall comply with each of the following:]
(A) [inserted: The practitioner shall—]
(i) [inserted: conduct outreach to the community involved concerning the practitioner’s treatment program; and]
(ii) [inserted: in conducting such outreach, give notice to community stakeholders including community boards, tenant associations, outpatient treatment centers, health care providers, community-based nonprofit organizations that provide opioid use and overdose prevention and treatment services, and such other community stakeholders as may be determined by the Secretary.]
(B) [inserted: The practitioner—]
(i) [inserted: shall develop and implement a neighborhood engagement plan that outlines the practitioner’s engagement with stakeholders referred to in subparagraph (A)(ii) in the geographic location in which the opioid treatment program is located; and]
(ii) [inserted: may include in such plan a description of the practitioner’s engagement with stakeholders, including homeowners associations, school administrators, neighboring businesses, community organizations, local councils, local emergency medical agencies, and law enforcement agencies.]
(C) [inserted: The practitioner shall—]
(i) [inserted: establish and maintain a community advisory board; and]
(ii) [inserted: include in the membership of such board volunteers from various stakeholder groups who represent the positions of the surrounding community.]
(D) [inserted: The practitioner—]
(i) [inserted: shall develop and implement a community relations plan to measure and minimize the negative impacts of the treatment program on the community; and]
(ii) [inserted: may include in such plan—]
(I) [inserted: policies and procedures to resolve community problems, including loitering and the blocking of pedestrian pathways;]
(II) [inserted: procedures to consider community input and impact; and]
(III) [inserted: a procedure to escalate and solve the quality-of-life issues in the surrounding blocks such as open air drug trading, uncapped needles disposed in public walkways, and open drug use.]
(3) [inserted: Reporting to Congress.—] [inserted: Not later than 1 year after the date of enactment of the Harm Reduction Through Community Engagement Act of 2025, and annually thereafter, the Secretary shall submit to the Congress a comprehensive report on community engagement and the maintenance of clinics in connection with maintenance treatment or detoxification treatment provided pursuant to this subsection, including—]
(A) [inserted: treatment performance measurement data;]
(B) [inserted: guidance on best practices for sustaining community engagement; and]
(C) [inserted: policy recommendations for sustaining community engagement.]
(i) Applicants for distribution of list I chemicals The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under clause (iv) or (v) of section 802(39)(A) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider—
(1) maintenance by the applicant of effective controls against diversion of listed chemicals into other than legitimate channels;
Rest of § 823 unchanged ·